2nd Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$2,130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

17 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Genetically Engineered (GE) Animals --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 -----Amendment on GE Salmon Labeling --One Health Legislation (Senate Discussion Draft) Review and Labeling of Food Derived From Biotechnology ---H.R. 1599: Safe and Accurate Food Labeling Act of 2015 ---U.S. Government Policy Funding for the USDA ---H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Potential Regulation of New Genetic Modification Technologies Funding for Biomass Crop Assistance Program ---H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Trade Promotion Authority ---HR 2146: Bipartisan Congressional Trade Priorities and Accountability Act of 2015 ---HR 1295: Trade Adjustment Assistance Act of 2015 Transatlantic Trade and Investment Partnership ---Ag-Biotech Issues Nutrition Policy ---Reauthorization of Federal School Nutrition Programs (Senate Discussion Draft)

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Medicare Payment Advisory Commission (MedPAC); SENATE; Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC)

Bills named: H.R. 3049 (114th), H.R. 1295 (114th), S. 1800 (114th), H.R. 2146 (114th), H.R. 1599 (114th)

Copyright/Patent/Trademark CPT

Patent Reform --H.R. 9: Innovation Act --Implementation of the America Invents Act of 2011 --S.1137: The PATENTS Act of 2015 Trans-Pacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade and Investment Partnership --Intellectual Property Issues Patenting of Biological Inventions --DNA Patenting and Licensing Trade Promotion Authority --HR 2146: Bipartisan Congressional Trade Priorities and Accountability Act of 2015 --HR 1295: Trade Adjustment Assistance Act of 2015 Inter Partes Review --H.R. 2578: Commerce, Science, Justice and Related Agencies Appropriations Act of FY 2016 --Implementation of the American Invents Act of 2011 --S. 1137: The PATENTS Act of 2015 --S. 632: STRONG Patents Act of 2011 --H.R. 9: Innovation Act Colombia National Development Plan --Intellectual Property Issues IP Rights for Environmental Technologies --U.S. Government Position for U.N. Convention on Climate Change Negotiations

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Office of the Vice President of the United States; SENATE; Food & Drug Administration (FDA); Natl Security Council (NSC); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH)

Bills named: H.R. 9 (114th), S. 632 (114th), S. 1137 (114th), H.R. 1295 (114th), H.R. 2146 (114th), H.R. 2578 (114th)

Clean Air and Water (quality) CAW

IP Rights for Environmental Technologies --U.S. Government Position for U.N. Convention on Climate Change Negotiations

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
TOM DILENGE —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Office of the Vice President of the United States; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA)

Consumer Issues/Safety/Products CSP

Genetically Engineered (GE) Animals --One Health Legislation (Senate Discussion Draft) --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ----Amendment on GE Salmon Labeling Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --U.S. Government Policy Biosimilars --Implementation of Affordable Care Act --Interchangeability and Pharmacy Substitution --Naming --Reimbursement Policy

Contacted: Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Natl Security Council (NSC); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Office of the Vice President of the United States; SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC)

Bills named: S. 1800 (114th), H.R. 3049 (114th), H.R. 1599 (114th)

Small Business SMB

Sarbanes Oxley Section 404 (b) --Public Company Accounting Oversight Board - Audit Cost Increases Capital Formation Investment Incentives --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --H.R. 2179: PARTNER Act --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act Expansion of Exemption under SEC Regulation A --H.R. 1839: Reforming Access for Investments in Startup Enterprises (RAISE) Act Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions --Fostering Innovation Act (House Discussion Draft) XBRL Exemption for Small Public Companies --H.R. 1965: Small Company Disclosure Simplification Act --H.R. 37: Promoting Job Creation and Reducing Small Business Burdens Act Capital Market Enhancements --SEC Office of Small Business Policy Responsibilities --H.R. 1525: Disclosure Modernization and Simplification Act --H.R. 1675/S.576: Encouraging Employee Ownership Act --H.R. 1723: Small Company Simple Registration Act --H.R. 2064: Improving Access to Capital for Emerging Growth Companies Act --H.R. 2357: Accelerating Access to Capital Act Proxy Advisory Services --Impact of Policies on Small Public Companies

Contacted: Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Health Resources & Services Administration (HRSA); U.S. Trade Representative (USTR); Office of the Vice President of the United States; Food & Drug Administration (FDA)

Bills named: H.R. 1675 (114th), H.R. 2357 (114th), H.R. 1839 (114th), H.R. 37 (114th), S. 537 (114th), H.R. 2179 (114th), H.R. 2064 (114th), H.R. 1525 (114th), S. 341 (114th), H.R. 1965 (114th), H.R. 1723 (114th), S. 576 (114th)

Trade (domestic/foreign) TRD

Foreign Agricultural Biotechnology Laws and Regulations --China Biotechnology Regulations --EU Ag Biotech Policies and Regulations Colombia National Development Plan --Regulatory Issues --Intellectual Property Issues Trans-Pacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals --Regulatory Transparency Transatlantic Trade and Investment Partnership --Ag-Biotech Issues --Regulatory Harmonization --Intellectual Property Issues --Reimbursement Transparency Trade Promotion Authority --H.R. 2146: Bipartisan Congressional Trade Priorities and Accountability Act of 2015 --H.R. 1295: Trade Adjustment Assistance Act of 2015 IP Rights for Environmental Technologies --U.S. Government Position for U.N. Convention on Climate Change Negotiations

Contacted: Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Office of the Vice President of the United States; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); SENATE; Natl Security Council (NSC); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA)

Bills named: H.R. 2146 (114th), H.R. 1295 (114th)

Taxation/Internal Revenue Code TAX

Renewable Chemicals/Bio-based Products --New Production Tax Credit --Expansion of Master Limited Partnerships to Renewable Chemicals --H.R. 2833/S.1656: Master Limited Partnerships Parity Act of 2015 Biofuels --Production Tax Credit Extension Research & Development Tax Credit Reforms --Extension --Permanency --H.R.880: To amend the Internal Revenue Code to make permanent the credit for increasing research activities --S. 537: COMPETE Act Capital Formation Investment Incentives --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act --H.R. 2179: PARTNER Act Tax Reform --Innovation/Patent Box Orphan Drug Act Tax Credit Inversions --H.R. 2995: Department of Financial Services and Related Agencies Appropriations Act for FY 2016

Contacted: HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Natl Institutes of Health (NIH); Medicare Payment Advisory Commission (MedPAC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Bills named: S. 341 (114th), H.R. 2833 (114th), H.R. 2995 (114th), H.R. 2179 (114th), S. 537 (114th), S. 1656 (114th), H.R. 880 (114th)

Health Issues HCR

Biosimilars --Naming --Interchangeability and Pharmacy Substitution --Implementation of Affordable Care Act --Patent Certification --Reimbursement Policy Funding for National Institutes of Health --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Centers for Disease Control and Prevention Vaccine Programs --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 340B Drug Pricing Program --Program Implementation & Oversight --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Medicaid Pricing and Rebates --Average Manufacturer Price Calculations --Implementation of Affordable Care Act Funding for FDA --H.R. 3049/S. 1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Biodefense Research, Development, and Procurement Issues Reimbursement for Innovative Products --Medicare Part D Prescription Drug Program --Medicare Part B Physician-Administered Products Sequestration of PDUFA Fees --HR 1078: Food and Drug Administration Safety over Sequestration Act of 2015 --Implementation of S. 365: Budget Control Act --S. 1413: FDA User Fee Protection Act Drug Evaluation and Review --Implementation of the FDA Safety and Innovation Act/Prescription Drug User Fee Act Orphan Drug Act Tax Credit 21st Century Cures Initiative --Biomarkers and Regulatory Science Improvements --Communication with Healthcare Professionals and Payers --Expanded Access to Investigational Drugs --Expedited Pathways --FDA Hiring Flexibility --FDA Management and Financial Accountability --Innovation Incentives --Longitudinal Study of Chronic Diseases --Patient Access to Approved Drugs --Patient-Focused Drug Development --Use of Real-World Evidence --Vaccine and Anti-Microbial Resistance Product Development and Incentives --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft) --Medicare Part D Low-Income Subsidy Increased Co-Pay --Biosimilars Reimbursement Policy --Authorized Generics Reimbursement Calculation --Reimbursement for Infusion Drugs under Medicare Part B Colombia National Development Plan --Regulatory Issues --Intellectual Property Issues Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Combating Antibiotic-Resistant Bacteria (CARB) Initiative --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft) Trans-Pacific Partnership --Data and Intellectual Property Protections for Pharmaceuticals --Regulatory Transparency Transatlantic Trade and Investment Partnership --Regulatory Harmonization --Intellectual Property Issues --Reimbursement Transparency Medicare Physician Payment Sustainable Growth Rate Formula --H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015

Contacted: Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States

Bills named: S. 1800 (114th), H.R. 3020 (114th), S. 1695 (114th), S. 1413 (114th), S. 365 (114th), H.R. 3049 (114th), H.R. 2 (114th), H.R. 1078 (114th)

Medicare/Medicaid MMM

Medicaid Pricing and Rebates --Average Manufacturer Price Calculations --Implementation of Affordable Care Act Reimbursement for Innovative Products --Medicare Part D Prescription Drug Program --Medicare Part B Physician-Administered Products Medicare Physician Payment Sustainable Growth Rate Formula --H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015 21st Century Cures Initiative --Patient Access to Approved Drugs --Medicare Part D Low-Income Subsidy Increased Co-Pay --Biosimilars Reimbursement Policy --Authorized Generics Reimbursement Calculations --Reimbursement for Infusion Drugs under Medicare Part B

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Office of the Vice President of the United States; SENATE; Health Resources & Services Administration (HRSA)

Bills named: H.R. 2 (114th)

Budget/Appropriations BUD

Funding for the USDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for FDA --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Centers for Disease Control and Prevention Vaccine Programs --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for National Institutes of Health --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Biomass Crop Assistance Program --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Sequestration of PDUFA Fees --HR 2725: Food and Drug Administration Safety over Sequestration Act of 2015 --Implementation of S. 365: Budget Control Act --S. 1413: FDA User Fee Protection Act Funding for Renewable Chemicals/Bio-based Products --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Biofuels --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Department of Defense Funding of Advanced Biofuels --H.R. 2685/S.1558: Department of Defense Appropriations Act for FY 2016 --H.R.2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016, --H.R.2822: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2016 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S.1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016

Contacted: SENATE; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Natl Security Council (NSC); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Office of the Vice President of the United States

Bills named: H.R. 2685 (114th), S. 1413 (114th), S. 1695 (114th), S. 1800 (114th), S. 365 (114th), H.R. 3020 (114th), H.R. 3049 (114th), H.R. 2725 (114th), H.R. 2028 (114th), H.R. 2822 (114th), S. 1558 (114th)

Chemicals/Chemical Industry CHM

Renewable Chemicals/Bio-based Products (Non-Funding) --Expansion of Master Limited Partnerships to Renewable Chemicals --H.R. 2833/S.1656: Master Limited Partnerships Parity Act of 2015 --Investment Tax Credit for Renewable Chemicals and Bio-based Products --New Production Tax Credit --S. 1447: Sustainable Chemistry Research and Development Act --S. 697: Chemical Safety for the 21st Century Act Funding for Renewable Chemicals/Bio-based Products and Biorefineries --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Energy Title IX, Section 9003

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
TOM DILENGE —
JEANNE HAGGERTY —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Office of the Vice President of the United States; SENATE

Bills named: H.R. 3049 (114th), S. 1800 (114th), H.R. 2833 (114th), S. 697 (114th), S. 1656 (114th), S. 1447 (114th)

Energy/Nuclear ENG

Biofuels (Non-Funding) --Implementation of the Agricultural Act of 2014 --Production Tax Credit Extension --Renewable Fuel Standard Funding for Biomass Crop Assistance Program --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Renewable Chemicals/Bio-based Products and Biorefineries --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Energy Title IX, Section 9003 Funding for Biofuels --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Department of Defense Funding of Advanced Biofuels --H.R. 2685/S.1558: Department of Defense Appropriations Act for FY 2016, --H.R. 2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --H.R.2822: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
TOM DILENGE —
CHARLES H FRITTS —
JEANNE HAGGERTY —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Medicare Payment Advisory Commission (MedPAC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; SENATE; Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC)

Bills named: H.R. 3049 (114th), H.R. 2028 (114th), S. 1558 (114th), H.R. 2822 (114th), H.R. 2685 (114th), S. 1800 (114th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ----Amendment on GE Salmon Labeling --One Health Legislation (Senate Discussion Draft) Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --U.S. Government Policy Nutrition Policy --Reauthorization of Federal School Nutrition Programs (Senate Discussion Draft)

LobbyistCovered position, as disclosed
TOM DILENGE —
JEANNE HAGGERTY —
A. CATHARINE HARRIS —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Security Council (NSC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of the Vice President of the United States; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA)

Bills named: H.R. 1599 (114th), S. 1800 (114th), H.R. 3049 (114th)

Animals ANI

Genetically Engineered (GE) Animals --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 ----Amendment on GE Salmon Labeling --One Health Legislation (Senate Discussion Draft)

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
JEANNE HAGGERTY —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Office of the Vice President of the United States; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA)

Bills named: S. 1800 (114th), H.R. 3049 (114th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) --Implementation of the Agricultural Act of 2014 --Production Tax Credit Extension --Renewable Fuel Standard Funding for Biomass Crop Assistance Program --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 Funding for Renewable Chemicals/Bio-based Products and Biorefineries --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014, Energy Title IX, Section 9003 Funding for Biofuels --H.R. 3049/S.1800: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2016 --Department of Defense Funding of Advanced Biofuels --H.R. 2685/S.1558: Department of Defense Appropriations Act for FY 2016, --H.R.2028: Energy and Water Development and Related Agencies Appropriations Act for FY 2016 --H.R.2822: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2016 --Implementation of the Agricultural Act of 2014

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
TOM DILENGE —
CHARLES H FRITTS —
JEANNE HAGGERTY —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Office of the Vice President of the United States; SENATE; Health & Human Services, Dept of (HHS); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES

Bills named: S. 1800 (114th), S. 1558 (114th), H.R. 2028 (114th), H.R. 2685 (114th), H.R. 2822 (114th), H.R. 3049 (114th)

Homeland Security HOM

Biodefense Research, Development, and Procurement Issues (Non-funding) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Combating Antibiotic-Resistant Bacteria (CARB) Initiative --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft)

Contacted: Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Office of the Vice President of the United States

Bills named: H.R. 3020 (114th), S. 1695 (114th)

Medical/Disease Research/Clinical Labs MED

Funding for National Institutes of Health --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 21st Century Cures Initiative --Longitudinal Study of Chronic Diseases Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --H.R. 3020/S. 1695: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2016 Combating Antibiotic-Resistant Bacteria (CARB) Initiative --ADAPT Act (House Discussion Draft) --DISARM Act (House Discussion Draft)

Contacted: Office of the Vice President of the United States; Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Securities & Exchange Commission (SEC); Natl Security Council (NSC); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 3020 (114th), S. 1695 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.